The U.S. Supreme Court heard the case about the regulations around mifepristone, one of a two-step regime for abortion medication, on Tuesday. FDA v. Alliance for Hippocratic Medicine initially questioned last year whether mifepristone could be on the market. The Alliance, with known ties to anti-abortion groups, claimed the FDA erred in its administrative regulations […]
